Johnson & Johnson (JNJ) Equity Ratio (2009 - 2026)

Johnson & Johnson (JNJ) has 18 years of Equity Ratio data on file, last reported at 0.4 in Q1 2026.

• Quarterly Equity Ratio changed 0.2% year-over-year to 0.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.4 (changed 0.2% YoY) and the FY2025 annual result came in at 0.41, up 3.12% from the prior year.
• Equity Ratio fell to 0.4 in Q1 2026 per JNJ's latest filing, from 0.41 in the prior quarter.
• The five-year high for Equity Ratio was 0.43 in Q3 2022, with the low at 0.36 in Q2 2023.
• Average Equity Ratio over 5 years is 0.41, with a median of 0.41 recorded in 2022.
• Year-over-year, Equity Ratio declined 13.67% in 2023 and advanced 12.59% in 2024.
• Johnson & Johnson's Equity Ratio stood at 0.43 in 2022, then dropped by 3.65% to 0.41 in 2023, then declined by 3.29% to 0.4 in 2024, then grew by 3.12% to 0.41 in 2025, then decreased by 1.27% to 0.4 in 2026.
• Business Quant data shows JNJ's Equity Ratio at 0.4 in Q1 2026, 0.41 in Q4 2025, and 0.41 in Q3 2025.